We’ve got news for you!
Follow us on our mission to lead the change towards better and more sustainable products in the new era of biomaterials. Here you will find a summary of our latest news and press releases. If you have any further questions please reach out to:
Isabel Rosenberger
Senior Manager Marketing & Communication
E-Mail: pr@amsilk.com
Tel: (+49) 89 5795393-0
Essen and Neuried, Germany. Evonik and AMSilk, a global leader in advanced biomaterials based on silk proteins, have deepened their collaboration with a long-term agreement to produce sustainable silk proteins at industrial scale
AMSilk today announced it has successfully secured EUR 52 million financing led by existing investor ATHOS (AT Newtec), along with strong participation from fellow existing investors MIG Capital and Novo Holdings.
AMSilk, a global leader in advanced biomaterials based on silk proteins, today announces its expansion into the consumer care market with the launch of AMSilk4Shine and AMSilk4Care.
AMSilk announces that the Company and Ajinomoto Foods Europe (AFE), a company with over 50 years of experience in industrial fermentation, and the affiliate of the globally established Ajinomoto group, have expressed mutual interest to step into a long-term partnership to biomanufacture silk proteins at Ajinomoto Foods Europe’s manufacturing facility in Nesle, France.
AMSilk announces it has been invited to join the World Economic Forum’s Global Innovators Community, an invite-only initiative, that was established in 2019 to bring together companies making strides to innovate and contribute meaningfully to solving the key issues faced by people and the planet.
AMSilk GmbH announces that it will be making its first appearance at Première Vision Paris, the largest textile trade show in Europe, from the 2-4 July 2024.
AMSilk today announces that it has completed an independent ‘Cradle-to-Gate’ Life Cycle Assessment (LCA) comparing the environmental footprint of AMSilk Ultrafine Fiber with mulberry silk across five environmental indicators
AMSilk today announces the appointments of Ralph Fraundorfer and Ctibor Kohutovic to its Management Board starting immediately.
AMSilk today announces the appointments of Ralph Fraundorfer and Ctibor Kohutovic to its Management Board starting immediately.
After a year of working together, BRAIN Biotech and AMSilk have specifically optimized a natural structural protein and subsequently registered the first PCT patent (“Patent Cooperation Treaty”) for this process.